Publications by authors named "L Locher"

Claim this Profile
G
Generic competition and price developments in the USA, Germany and Switzerland (2007-2023): a longitudinal observational study.
Simon Hediger, Luca Locher, Kerstin Noëlle Vokinger

BMJ Public Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Confidential and non-confidential drug rebates in Switzerland, 2013-2023: empirical analysis of drug rebates, trends over time and re-evaluations" [The Lancet Regional Health-Europe, volume 46, November 2024, 101094].
Noah Rohner, Cascal Herrle, Luca Locher, Kerstin N Vokinger

Lancet Reg Health Eur· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why effect sizes are systematically larger for progression-free survival than overall survival in cancer drug trials: Prognostic scores as a way forward.
Luca Locher, Miquel Serra-Burriel, Dario Trapani, Emanuel Nussli, Kerstin N Vokinger

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confidential and non-confidential drug rebates in Switzerland, 2013-2023: empirical analysis of drug rebates, trends over time and re-evaluations.
Noah Rohner, Cascal Herrle, Luca Locher, Kerstin N Vokinger

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022.
Cécile Emeraud, Delphine Girlich, Manon Deschamps, Inès Rezzoug, Aymeric Jacquemin, Lucy Locher

Emerg Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis